Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.46
    +2.34 (+0.31%)
     
  • GBP/EUR

    1.1672
    +0.0016 (+0.13%)
     
  • GBP/USD

    1.2472
    -0.0039 (-0.31%)
     
  • Bitcoin GBP

    50,897.34
    -507.47 (-0.99%)
     
  • CMC Crypto 200

    1,322.59
    -73.95 (-5.30%)
     
  • S&P 500

    5,099.72
    +51.30 (+1.02%)
     
  • DOW

    38,241.64
    +155.84 (+0.41%)
     
  • CRUDE OIL

    83.87
    +0.30 (+0.36%)
     
  • GOLD FUTURES

    2,348.30
    +5.80 (+0.25%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

This News May Hand the Vaccine Market Over to Pfizer and Moderna

This News May Hand the Vaccine Market Over to Pfizer and Moderna

It's fair to say that Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are dominating the coronavirus vaccine market these days. Their vaccines have fully immunized 86 million and 62 million Americans, respectively.